Therapeutic Effect of Abelmoschus manihot on Type 2 Diabetic Nonproliferative Retinopathy and the Involvement of VEGF
Table 3
Comparisons of biochemical indicators and blood pressure between two groups before and after treatment.
T group
C group
Before (n = 40)
After (n = 38)
Before (n = 40)
After (n = 39)
FBG (mmol/L)
8.7 ± 2.6
7.8 ± 1.9
8.2 ± 2.9
8.1 ± 2.2
0.37
0.47
PBG (mmol/L)
12.7 ± 2.2
10.5 ± 2.1
11.9 ± 3.0
10.8 ± 2.5
0.19
0.49
HbA1c (%)
8.8 ± 1.7
7.8 ± 1.8
9.1 ± 2.4
7.8 ± 1.4
0.51
0.95
TC (mmol/L)
4.3 ± 1.0
4.3 ± 1.0
4.1 ± 1.0
4.2 ± 1.0
0.41
0.53
TG (mmol/L)
1.7 (1.1, 2.4)
1.5 (1.2, 2.2)
1.6 (1.1, 2.5)
1.7 (1.1, 2.2)
0.77
0.74
HDL (mmol/L)
1.2 ± 0.3
1.4 ± 0.3
1.2 ± 0.3
1.3 ± 0.3
0.74
0.13
LDL (mmol/L)
2.7 ± 0.8
2.9 ± 0.9
2.5 ± 0.8
2.8 ± 1.0
0.48
0.70
ALT (U/L)
26 (18, 42)
29 (20, 38)
30 (19, 40)
29 (21, 35)
0.60
0.77
AST (U/L)
22 (17, 27)
22 (19, 28)
22 (18, 28)
23 (20, 29)
0.42
0.56
BUN (mmol/L)
6.7 ± 2.0
6.5 ± 1.5
6.2 ± 1.2
6.0 ± 1.3
0.22
0.14
Scr (umol/L)
67 (60, 81)
71 (61, 80)
68 (57, 75)
70 (58, 76)
0.61
0.50
eGFR (mL/min)
97.5 ± 25.7
98.3 ± 22.1
99.8 ± 17.2
98.8 ± 16.6
0.64
0.91
SBP (mmHg)
128 ± 12
129 ± 8
126 ± 10
130 ± 8
0.32
0.93
DBP (mmHg)
75 ± 10
77 ± 5
76 ± 8
78 ± 6
0.54
0.31
T: treatment; C: control; SBP: systolic blood pressure; DBP: diastolic blood pressure; P1: T group vs C group before treatment; P2: T group vs C group after treatment.
